Kaiser Permanent Southern California has some bold ambitions for colon cancer in the coming years: last week the organization pledged to cut the number of colon cancer deaths in half by the year 2023.
At the American Society of Clinical Oncology Quality Care Symposium in Boston October 17th, Kaiser Permanente Southern California announced their goal to reduce colorectal mortality by 50 percent in the next decade from its baseline measurement of 13.8 deaths/100,000 people to 6.9 deaths/100,000 people.
This health care organization serves 3.7 million members, and plans to effectuate this lofty goal through a concentrated focus on all aspects of colon cancer care — prevention, screening, diagnosis, treatment and survivorship.
"Setting this bold goal is really unprecedented, but we are in a unique position to be able to achieve it," said Michael Kanter, MD, medical director, quality and clinical analysis, Southern California Permanente Medical Group in a recent press release. "We're already consistently engaging in successful practices and using effective tools that will help us accomplish our mission." Dr. Kanter is referring to the fact that Kaiser Permanente Southern California's five-year colon cancer survival rate is 75 percent - 10 percent higher than the national average.
This is not the organization's first contribution to the fight against colon cancer. By the end of 2013, colon cancer screening rates among Kaiser Permanente Southern California members rose to 83 percent, due in part to the success of several screening programs launched last March during Colon Cancer Awareness Month.
Be Seen, Get Screened applauds Kaiser Permanente Southern California's continued commitment to the fight against colon cancer.
Other News From Around the Web
- A new study found that 62 percent of colon cancer patients reported a significant financial burden due to treatment.
- A new study on the recent increase in young-onset cancer suggests the need to improve colorectal cancer screening strategies for the younger patient population.
- The risk of both colorectal cancer and CRC-related mortality can be reduced in patients with inflammatory bowel disease by adhering to guideline-directed colonoscopy surveillance recommendations, according to new research.
- Here's a blog post from Fight Colorectal Cancer that explains why disease awareness should be "color blind."